Andrew D. Leavitt

Dr. Andrew D. Leavitt is a Professor at the University of California, San Francisco (UCSF) School of Medicine, Department of Medicine. He is a key figure in the Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program, where he serves as director of the program for noncancerous blood disorders and director of the UCSF Adult Hemophilia Treatment Center. Additionally, he is the medical director of UCSF's blood and marrow transplant clinical laboratory.

• Full Name: Andrew D. Leavitt
• Institution: University of California, San Francisco
• School: School of Medicine
• Department: Department of Medicine
• Academic Rank: Professor
• Status: Active Faculty
• Primary Program: Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC)

Education:

• Medical Degree: Harvard Medical School, 1984
• Residency: Internal Medicine, University of Michigan Hospitals and Health Centers, 1988
• Fellowship: Hematology, UCSF, 1991
• Fellowship: Transfusion Medicine (Blood Banking), UCSF, 1992

Research and Clinical Interests:
Dr. Leavitt is internationally recognized for his research on megakaryocyte development and platelet production. His clinical and scientific work focuses on improving treatments and outcomes for patients with bleeding disorders such as hemophilia and von Willebrand disease, as well as venous thromboembolic diseases. He also manages patients with platelet function disorders, immune thrombocytopenia, thrombotic thrombocytopenic purpura, neutropenia, and anemia.

Professional Service and Recognition:
Dr. Leavitt has served on expert guideline panels for venous thromboembolism treatment in cancer patients and has contributed to the scientific community through editorial roles on prestigious journals including Blood, the Journal of Clinical Investigation, and the Journal of Clinical and Translational Science.

Clinical Leadership and Patient Care:
He is deeply involved in patient care, leading specialized centers such as the Adult Hemophilia Treatment Center and the HHT Center of Excellence. Patient reviews consistently highlight his compassion, expertise, and exceptional communication skills.

Laboratory and Program Leadership:
As medical director of the blood and marrow transplant clinical laboratory, Dr. Leavitt plays a critical role in supporting cellular therapy programs at UCSF, ensuring high standards in blood and marrow processing and transfusion safety.